Latest Insider Transactions at Intuitive Surgical Inc (ISRG)
This section provides a real-time view of insider transactions for Intuitive Surgical Inc (ISRG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of INTUITIVE SURGICAL INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of INTUITIVE SURGICAL INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 09
2020
|
Gary S Guthart CEO |
SELL
Open market or private sale
|
Indirect |
5,800
-20.0%
|
$4,396,400
$758.38 P/Share
|
|
Dec 08
2020
|
Gary S Guthart CEO |
BUY
Bona fide gift
|
Indirect |
29,000
+50.0%
|
-
|
|
Dec 08
2020
|
Gary S Guthart CEO |
SELL
Bona fide gift
|
Indirect |
35,800
-24.77%
|
-
|
|
Dec 08
2020
|
Gary S Guthart CEO |
SELL
Open market or private sale
|
Direct |
11,114
-4.22%
|
$8,457,754
$761.76 P/Share
|
|
Dec 08
2020
|
Gary S Guthart CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
14,000
+5.05%
|
$2,352,000
$168.41 P/Share
|
|
Dec 07
2020
|
Jamie Samath EVP & CFO & Enterprise Technol |
SELL
Open market or private sale
|
Direct |
407
-20.37%
|
$316,646
$778.0 P/Share
|
|
Dec 07
2020
|
Jamie Samath EVP & CFO & Enterprise Technol |
BUY
Exercise of conversion of derivative security
|
Direct |
407
+16.41%
|
$179,487
$441.58 P/Share
|
|
Dec 01
2020
|
Marshall Mohr Executive VP Global Business S |
SELL
Bona fide gift
|
Direct |
1,400
-9.54%
|
-
|
|
Oct 26
2020
|
Marshall Mohr Executive VP Global Business S |
SELL
Open market or private sale
|
Direct |
6,000
-29.02%
|
$4,290,000
$715.28 P/Share
|
|
Oct 26
2020
|
Marshall Mohr Executive VP Global Business S |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+22.49%
|
$762,000
$127.91 P/Share
|
|
Oct 20
2020
|
Alan J Levy Director |
SELL
Open market or private sale
|
Direct |
1,800
-18.67%
|
$1,324,800
$736.12 P/Share
|
|
Oct 20
2020
|
Alan J Levy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,800
+15.74%
|
$347,400
$193.08 P/Share
|
|
Oct 20
2020
|
Jamie Samath EVP & CFO & Enterprise Technol |
SELL
Open market or private sale
|
Direct |
754
-37.02%
|
$554,944
$736.12 P/Share
|
|
Oct 20
2020
|
Jamie Samath EVP & CFO & Enterprise Technol |
BUY
Exercise of conversion of derivative security
|
Direct |
754
+26.85%
|
$321,204
$426.18 P/Share
|
|
Oct 20
2020
|
Reiter Kara Andersen Sr VP General Counsel & CCO |
SELL
Open market or private sale
|
Direct |
1,250
-23.51%
|
$920,000
$736.12 P/Share
|
|
Oct 20
2020
|
Reiter Kara Andersen Sr VP General Counsel & CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+19.03%
|
$212,500
$170.76 P/Share
|
|
Oct 20
2020
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
875
-22.66%
|
$644,000
$736.12 P/Share
|
|
Oct 20
2020
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
875
+18.48%
|
$208,250
$238.91 P/Share
|
|
Feb 19
2019
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,938
-96.9%
|
$1,595,334
$543.51 P/Share
|